4/A

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: April 16, 2004
Period of Report: December 15, 2003
Accession Number: 0001237899-04-000025

View Document ↗ View on SEC.gov ↗